Common Variable Immunodeficiency clinical trials at University of California Health
1 research study open to eligible people
Showing trials for
Abatacept for the Treatment of Common Variable Immunodeficiency With Interstitial Lung Disease
open to eligible people ages 4 years and up
There is no standard of care therapy for patients with granulomatous-lymphocytic interstitial lung disease (GLILD) seen in common variable immunodeficiency (CVID). Abatacept has recently looked promising for the treatment of patients with complex…
at UCSF
Our lead scientists for Common Variable Immunodeficiency research studies include Michele Pham, MD.
Last updated: